Your browser doesn't support javascript.
loading
Engaging European society at the forefront of cancer research and care: How discussions at the 5th Gago Conference on European Science policy led to the Heidelberg Manifesto
Baumann, Michael; Celis, Julio; Ringborg, Ulrik; Heitor, Manuel; Berns, Anton; Albreht, Tit; Arabadjiev, Jeliazko; Boutros, Michael; Brandenburg, Mario; Canhao, Helena; Carneiro, Fatima; Chomienne, Christine; De Lorenzo, Francesco; Eggermont, Alexander M M; Font, Angel; Garralda, Elena; Goulart, Margarida; Henrique, Rui; Lawler, Mark; Maier-Hein, Lena; Meunier, Francoise; Oberst, Simon; Oliveira, Pedro; Papatriantafyllou, Maria; Schüz, Joachim; Solary, Eric; Valencia, Alfonso; Vargas, Rosalia; Weiderpass, Elisabete; Wilking, Nils.
Afiliação
  • Baumann M; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Celis J; European Academy of Cancer Sciences, Stockholm, Sweden.
  • Ringborg U; European Academy of Cancer Sciences, Stockholm, Sweden.
  • Heitor M; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Berns A; European Academy of Cancer Sciences, Stockholm, Sweden.
  • Albreht T; Cancer Center Karolinska, Karolinska University Hospital, Stockholm, Sweden.
  • Arabadjiev J; European Academy of Cancer Sciences, Stockholm, Sweden.
  • Boutros M; Center for Innovation, Technology and Policy Research, IN+ @ IS Técnico, University of Lisbon, Portugal.
  • Brandenburg M; European Academy of Cancer Sciences, Stockholm, Sweden.
  • Canhao H; The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Carneiro F; National Institute of Public Health of Slovenia, Ljubljana, Slovenia.
  • Chomienne C; Faculty of Medicine, University of Ljubljana, Slovenia.
  • De Lorenzo F; Clinic of Medical Oncology, University Hospital Acibadem City Clinic Tokuda, Sofia, Bulgaria.
  • Eggermont AMM; Bulgarian Scientific Society of Immuno-oncology, and MoC Board, Sofia, Bulgaria.
  • Font A; European Academy of Cancer Sciences, Stockholm, Sweden.
  • Garralda E; Division Signaling and Functional Genomics, German Cancer Research Center (DKFZ) and Heidelberg University, Germany.
  • Goulart M; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany.
  • Henrique R; Federal Ministry of Education and Research (BMBF), Berlin, Germany.
  • Lawler M; Comprehensive Health Research Center (CHRC), NOVA Medical School, Universidade Nova de Lisboa, Portugal.
  • Maier-Hein L; European Academy of Cancer Sciences, Stockholm, Sweden.
  • Meunier F; Instituto de Patologia e Imunologia Molecular da Universidade do Porto (Ipatimup), Portugal.
  • Oberst S; Instituto de Investigação e Inovação em Saúde (i3S), Faculdade de Medicina da Universidade do Porto (FMUP), Portugal.
  • Oliveira P; Centro Hospitalar Universitário de São João (CHUSJ), Porto, Portugal.
  • Papatriantafyllou M; Université de Paris, France.
  • Schüz J; European Academy of Cancer Sciences, Stockholm, Sweden.
  • Solary E; European Cancer Patient Coalition, Brussels, Belgium.
  • Valencia A; European Academy of Cancer Sciences, Stockholm, Sweden.
  • Vargas R; Department Cancer Medicine, CSO Princess Máxima Centre Pediatric Oncology, University Medical Center Utrecht, The Netherlands.
  • Weiderpass E; Board of the Comprehensive Cancer Center Munich, Technical University Munich, Germany.
  • Wilking N; Ludwig Maximiliaan University, Munich, Germany.
Mol Oncol ; 17(6): 925-945, 2023 06.
Article em En | MEDLINE | ID: mdl-36938773
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Mol Oncol Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Mol Oncol Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha